Our experts leverage years of cancer genomic and bioinformatics experience and Oncomine® Platform enabled research capabilities to help answer your critical cancer research questions.
- Novel target discovery and validation
- Selection of patient populations for targeted therapies
- Identification of predictive genomic biomarkers
- Characterization of molecular subtypes of disease
- Integrated analysis of new and emerging data types (NGS)